Mirati Therapeutics Overview
Mirati Therapeutics Discounted Cash Flow
DCF Analysis for MRTX.
Get informed when a big investor buys or sells
+ FollowFair Value
$66.66
Current Fair Value
$66.66
↑ 13.6% Upside
Undervalued by 13.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison